Disclaimer: This article was published in 2024 and reflects the information available at that time.
Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to their patients. With pharmacists now becoming accustomed to these changes, the PDL Professional Officers wanted to take the opportunity to highlight some common incidents involving the OTP that have been reported to PDL. Dose calculation errors – where a methadone dose has been expressed as xmg, but xmL has been supplied, leading to the patient ingesting five times the prescribed dose. Wrong patien…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article
Tasmania pilot to commence 1st March
22 February 2024
TASDispensingProfessional activitiesScope of practiceRegulatory and compliancePharmacist prescribing
Learn more